Axcelis Technologies (ACLS) Wins Purion XEmax Foundry Spot On An Undervalued Narrative
Axcelis Technologies event overview
Axcelis Technologies (ACLS) recently reported the successful evaluation closure of its Purion XEmax high energy implanter at a foundry, with the tool selected for Power Management Integrated Circuit production at energies up to 15 MeV.
See our latest analysis for Axcelis Technologies.
Axcelis Technologies shares have given up some ground recently, with the 7 day share price return down 16.19% and the 30 day share price return down 30.71%. However, the year to date share price return is 39.38% and the 1 year total shareholder return is 64.04%, which points to longer term momentum still being positive despite the recent pullback.
If the Purion XEmax news has you thinking about where else growth in chip equipment and infrastructure might show up, it could be worth scanning 56 AI infrastructure stocks
Bulls see Axcelis Technologies as a specialist gaining traction with tools like Purion XEmax, while bears point to the sharp recent share price pullback. Which side does the current valuation really support next?
Most Popular Narrative: 29.3% Undervalued
Axcelis Technologies last closed at $120.03, while the most widely followed narrative places fair value closer to $169.67. That gap rests on a detailed set of growth, margin and valuation assumptions.
Ongoing R&D investments and next-generation Purion platform enhancements are driving increased customer engagement, particularly around advanced node processes (trench and super junction devices), enabling Axcelis to win share in premium market segments and supporting future gross margin improvement.
Want to see what kind of revenue path and profit profile Axcelis Technologies would need to support that fair value? The narrative leans on modest top line expansion, thinner margins than today and a richer future earnings multiple tied to semiconductor demand cycles.
Result: Fair Value of $169.67 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Axcelis Technologies also faces meaningful risks, including its heavy China exposure and the possibility that slower adoption of advanced power device technologies could cap tool demand.
Find out about the key risks to this Axcelis Technologies narrative.
Another view on Axcelis Technologies valuation
The SWS DCF model tells a very different story to the narrative fair value of $169.67. On this approach, Axcelis Technologies at about $120 is trading well above an estimated future cash flow value of $20.28, which points to an overvalued result instead of a 29.3% undervalued gap. Which framework do you find more convincing?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Axcelis Technologies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With both risks and rewards on the table for Axcelis Technologies, sentiment is clearly mixed. Move quickly, review the data yourself and weigh the 3 key rewards and 3 important warning signs
Looking for more investment ideas beyond Axcelis Technologies?
If Axcelis Technologies has your attention, do not stop here. Use the Simply Wall St Screener to spot fresh opportunities before they move without you.
- Target potential mispricings by reviewing 49 high quality undervalued stocks that combine solid fundamentals with room for a stronger share price story.
- Secure your income focus by scanning 8 dividend fortresses that aim to pair higher yields with business resilience.
- Prioritize capital protection by checking 83 resilient stocks with low risk scores that score well on financial strength and volatility.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com